2020 BOPA Symposium Information

Due to the COVID-19 pandemic, the BOPA Committee made the decision to change the format of the 2020 conference from a face-to-face to a virtual format.

BOPA are working hard to ensure that your experience of the conference is as stimulating and interesting as a face-to-face conference in a virtual way.

For all your questions answered, please CLICK HERE for more information and CLICK HERE for the FAQs we have developed for you.

 

Registration now open – Click HERE to register

 

BOPA are delighted to offer members a special discounted rate of £99.00 to attend the 3 day virtual conference in October.

To take advantage of this offer, you must register before the 14th September 2020.

The BOPA 2020 conference will offer you a full virtual experience and the opportunity to take part in every aspect of the programme including:

• Access to all presentations and session recordings
• Visit the virtual exhibition hall
• Network with colleagues
• Access all the e-posters
• Join in live discussions
• Give feedback

Payment of registration fees must be made after completing the registration process.

We look forward to welcoming you virtually to the conference.

With best wishes

BOPA 2020 Congress Organiser
Media1 Productions Ltd
E: [email protected]
WWW.MEDIA1PRODUCTIONS.CO.UK

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article